T 0885/21 (Modified antibody / SYNAFFIX) of 14.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T088521.20230914
- Date of decision
- 14 September 2023
- Case number
- T 0885/21
- Petition for review of
- -
- Application number
- 13786322.1
- IPC class
- A61K 47/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MODIFIED ANTIBODY, ANTIBODY-CONJUGATE AND PROCESS FOR THE PREPARATION THEREOF
- Applicant name
- Synaffix B.V.
- Opponent name
- HGF Limited
Glykos Finland Oy
Genovis Ab - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 123(2)European Patent Convention Art 54(2)European Patent Convention Art 54(4)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Amendment to case - main request admitted (yes)
Late submitted objections - admitted (no)
Claims - clarity (yes)
Amendments - added subject-matter (no)
Sufficiency of disclosure (yes)
Sufficiency of disclosure - serious doubts (no)
Novelty - availability to the public (yes)
Novelty - implicit disclosure medical use (no)
Inventive step - relevance post-published evidence (yes)
Inventive step - unexpected improvement (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain a patent on the basis of claims 1-8 of the main request filed as auxiliary request 1 with the statement of grounds of appeal and a description to be adapted thereto.